AGÕæÈ˹ٷ½

STOCK TITAN

Rocket Pharmaceu SEC Filings

RCKT NASDAQ

Welcome to our dedicated page for Rocket Pharmaceu SEC filings (Ticker: RCKT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Rocket Pharmaceuticals� 10-K isn’t just numbers—it’s 250+ pages of gene-therapy science, trial protocols and dilution math that can overwhelm even seasoned analysts. If you’re trying to pinpoint when a lentiviral program moves from Phase 1 to Phase 2, trace cash-burn trends, or monitor executive stock sales, traditional SEC readers make the search slow. That complexity is exactly why our AI-powered Stock Titan hub exists.

Every submission—from a Rocket Pharmaceuticals quarterly earnings report 10-Q filing to the next Rocket Pharmaceuticals 8-K material events explained—appears here seconds after hitting EDGAR. Our engine produces plain-English summaries, highlights trial-related risk factors and surfaces critical numbers. Need governance details? The Rocket Pharmaceuticals proxy statement executive compensation section is broken down so you see option grants alongside milestone-based bonuses. Tracking insider sentiment? Receive alerts for Rocket Pharmaceuticals insider trading Form 4 transactions and view Rocket Pharmaceuticals Form 4 insider transactions real-time. Key filing insights include:

  • Pipeline spend vs. runway in every Rocket Pharmaceuticals annual report 10-K simplified
  • Sequential data on trial enrollment from each 10-Q earnings update
  • Cash-raising shelf registrations flagged within S-3 filings
  • Director buys and sells via Rocket Pharmaceuticals executive stock transactions Form 4
  • Partnership or FDA feedback disclosed through 8-K items

With AI-generated redline comparisons and exportable tables, understanding Rocket Pharmaceuticals SEC documents with AI becomes practical—not a weekend project. Use our concise Rocket Pharmaceuticals earnings report filing analysis to gauge milestone catalysts, or set custom watchlists so you never miss the next data-driven move. Complex biotech filings, clarified and delivered in real time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.46%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Rocket Pharmaceu (RCKT)?

The current stock price of Rocket Pharmaceu (RCKT) is $3.75 as of August 20, 2025.

What is the market cap of Rocket Pharmaceu (RCKT)?

The market cap of Rocket Pharmaceu (RCKT) is approximately 326.9M.
Rocket Pharmaceu

NASDAQ:RCKT

RCKT Rankings

RCKT Stock Data

326.95M
104.27M
3.03%
91.39%
10.41%
Biotechnology
Pharmaceutical Preparations
United States
NEW YORK